Fuller & Thaler Asset Management, Inc. Axogen, Inc. Transaction History
Fuller & Thaler Asset Management, Inc.
- $25 Billion
- Q3 2024
A detailed history of Fuller & Thaler Asset Management, Inc. transactions in Axogen, Inc. stock. As of the latest transaction made, Fuller & Thaler Asset Management, Inc. holds 44,625 shares of AXGN stock, worth $646,170. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,625Holding current value
$646,170% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding AXGN
# of Institutions
163Shares Held
36.6MCall Options Held
230KPut Options Held
400-
First Light Asset Management, LLC Edina, MN4.09MShares$59.2 Million5.0% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$47.1 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.01MShares$43.5 Million3.58% of portfolio
-
Morgan Stanley New York, NY2.9MShares$42 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$35.1 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $612M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...